Trevena
TRVN
#11371
Rank
NZ$0 M
Marketcap
NZ$0.0009140
Share price
0.00%
Change (1 day)
-94.87%
Change (1 year)

Market capitalization of Trevena (TRVN)

Market cap: NZ$0 Million

As of November 2026 Trevena has a market cap of NZ$0 Million. This makes Trevena the world's 11371th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Trevena from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0 M-95.6%
2025NZ$0.01 M-99.36%
2024NZ$2.81 M-83.73%
2023NZ$17.32 M10.69%
2022NZ$15.65 M-88.84%
2021NZ$0.14 B-70.43%
2020NZ$0.47 B303.4%
2019NZ$0.11 B122.9%
2018NZ$52.77 M-62.4%
2017NZ$0.14 B-68.41%
2016NZ$0.44 B-43%
2015NZ$0.77 B160.23%
2014NZ$0.29 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$430.75 B 54,673,476,325.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$602.60 B 76,485,537,340.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.83 B 106,480,449.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$12.93 B 1,641,258,309.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$26.65 M 3,382,493.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$14.82 M 1,881,698.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
NZ$11.27 B 1,430,469,334.80%๐Ÿ‡บ๐Ÿ‡ธ USA